| __timestamp | TG Therapeutics, Inc. | Xencor, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 24518692 | 7461000 |
| Thursday, January 1, 2015 | 19886580 | 11960000 |
| Friday, January 1, 2016 | 12631689 | 13108000 |
| Sunday, January 1, 2017 | 21977998 | 17501000 |
| Monday, January 1, 2018 | 20759000 | 22472000 |
| Tuesday, January 1, 2019 | 20838000 | 24286000 |
| Wednesday, January 1, 2020 | 121812000 | 29689000 |
| Friday, January 1, 2021 | 152137000 | 38837000 |
| Saturday, January 1, 2022 | 83231000 | 47489000 |
| Sunday, January 1, 2023 | 122706000 | 53379000 |
Unleashing insights
In the competitive world of biotechnology, managing operational costs is crucial. This analysis compares the Selling, General, and Administrative (SG&A) expenses of TG Therapeutics, Inc. and Xencor, Inc. from 2014 to 2023. Over this period, TG Therapeutics saw a dramatic increase in SG&A expenses, peaking in 2021 with a 1,200% rise from 2014. In contrast, Xencor's expenses grew steadily, with a 615% increase over the same period. Notably, TG Therapeutics' expenses surged in 2020, coinciding with significant product development phases. Meanwhile, Xencor maintained a more consistent growth trajectory, reflecting its strategic focus on sustainable expansion. This comparison highlights the diverse financial strategies within the biotech sector, offering insights into how companies allocate resources to drive innovation and growth.
Who Optimizes SG&A Costs Better? Johnson & Johnson or Xencor, Inc.
SG&A Efficiency Analysis: Comparing Neurocrine Biosciences, Inc. and Xencor, Inc.
Operational Costs Compared: SG&A Analysis of Blueprint Medicines Corporation and Xencor, Inc.
Selling, General, and Administrative Costs: Lantheus Holdings, Inc. vs TG Therapeutics, Inc.
Lantheus Holdings, Inc. and Xencor, Inc.: SG&A Spending Patterns Compared
Grifols, S.A. vs Xencor, Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing TG Therapeutics, Inc. and PTC Therapeutics, Inc.
Breaking Down SG&A Expenses: TG Therapeutics, Inc. vs Ligand Pharmaceuticals Incorporated
Comparing SG&A Expenses: TG Therapeutics, Inc. vs ImmunityBio, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? CymaBay Therapeutics, Inc. or Xencor, Inc.
Comparing SG&A Expenses: Veracyte, Inc. vs Xencor, Inc. Trends and Insights
Operational Costs Compared: SG&A Analysis of Supernus Pharmaceuticals, Inc. and Xencor, Inc.